Studies on the effects of methylmercury on ethylmorphine N-demethylase and aniline hydroxylase activities and on the conversion of cytochrome P-450 to cytochrome P-420.
D000814:Aniline Compounds; D000818:Animals; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003579:Cytochrome Reductases / Q000378:metabolism; D003574:Cytochrome c Group; D003600:Cytosol / Q000201:enzymology; D003640:Dealkylation; D003956:Dialysis; D006591:Hexobarbital / Q000494:pharmacology; D006900:Hydroxylation; D066298:In Vitro Techniques; D007700:Kinetics; D008099:Liver / Q000166:cytology; D008297:Male; D008767:Methylmercury Compounds / Q000494:pharmacology*; D008780:Methyltransferases / Q000037:antagonists & inhibitors*; D008862:Microsomes, Liver / Q000201:enzymology; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D009019:Morphinans; D009249:NADP; D010084:Oxidation-Reduction; D051381:Rats; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
D000814:Aniline Compounds; D065607:Cytochrome P-450 Enzyme Inhibitors; D003574:Cytochrome c Group; D008767:Methylmercury Compounds; D009019:Morphinans; D009249:NADP; D003577:Cytochrome P-450 Enzyme System; D006591:Hexobarbital; D006899:Mixed Function Oxygenases; D003579:Cytochrome Reductases; D008780:Methyltransferases